Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Rhythm Appoints Board Members

This article was originally published in Scrip

Executive Summary

Rhythm has appointed David Meeker, president and CEO of Sanofi's subsidiary Genzyme, and David McGirr, former chief financial officer of Cubist Pharmaceuticals, to its board of directors. Before joining Genzyme in 1994, Meeker was director of the Pulmonary Critical Care Fellowship at the Cleveland Clinic and assistant professor of medicine at Ohio State University. Previously, McGirr was senior advisor to the CEO of Cubist and from 2002 to 2013; he was senior vice president and CFO of the company. Prior to Cubist, McGirr was president and chief operating officer of internet technology company Hippo Inc., and he previously served as president and CEO of GAB Robins North America, Inc.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst